Please Wait...


Bioclinica will be exhibiting, attending and hosting numerous events in the coming months, from bio-imaging events to clinical data conferences. Please check our schedule of activities and trade shows, and come visit with us when we are in your area.

Use the Filter Events By Month below to select the specific Month and Year you would like to see.

September 6, 2017 - 1:00am (EDT) to September 7, 2017 - 1:00am (EDT)

Outsourcing in Clinical Trials New England

Join Bioclinica in Boston for OCT New England on September 6-7. Our team is happy to answer any questions you might have about Medical Imaging, Cardiac Safety, Biomarkers, Post-Approval Research, Patient Recruitment & Retention, and eHealth technologies. Come network with our team in the Bioclinica exhibit, #67.

Event Type: Conference

September 8, 2017 - 1:00am (EDT) to September 12, 2017 - 1:00am (EDT)

ESMO 2017 Congress

Bioclinica advances oncology research with comprehensive medical imaging and cardiac safety core lab services and molecular marker laboratory solutions. We are excited to exhibit during this year's ESMO, occurring September 8-12 in Madrid, Spain.

While in Madrid, join us on exhibit #106 to connect with our Oncology team as they share scientific, operational and regulatory insight to aid in advancing your oncology program. Pre-arrange a meeting with our team here.

Event Type: Conference

September 9, 2017 - 1:00am (EDT) to September 12, 2017 - 1:00am (EDT)

National Harbor, Maryland, USA

Meet with the industry-leading Bioclinica Safety & Regulatory Solutions division during the annual RAPS Convergence and learn about innovative solutions to meet your regulatory affairs objectives. Come network with our team in the Bioclinica exhibit, #610. We look forward to seeing you at the event-of-the-year where regulatory affairs specialists from around the world will convene to exchange ideas, knowledge and experiences.

Event Type: Exhibit

September 13, 2017 - 10:00am (EDT)

This webinar will highlight the use of more innovative agile methodologies to achieve better project delivery predictability, streamlined processes and high quality studies. Through case studies, presenters will share insight into improving quality and reducing risk while accelerating timelines.

Event Type: Webinar

September 14, 2017 - 1:00am (EDT) to September 15, 2017 - 1:00am (EDT)

Barcelona, Spain

Join Bioclinica risk-based monitoring and quality management experts in Barcelona for CBI and UBM's 2nd Annual Global Risk-Based Monitoring conference. Learn strategies to aid in reducing the complexities of implementing efficient RBM methodologies and gain real-life study examples. Stop by the Bioclinica exhibit and get answers to your questions around ICH E6 guidelines. Come away with a better understanding of the implications on risk, identification, evaluation, control, review and reporting, and technology-enabled solutions.

Event Type: Exhibit

September 18, 2017 - 10:00am (EDT)

One of the most important milestones in any trial is database (DB) lock. A key step towards DB lock is tracking that all activities are completed and clean for each patient (coding, external data reconciliation, query status, etc.). This can often be a challenge, especially for studies with large amounts of data. How do you track these many disparate activities for each patient? How do you predict if you are on track to meet the planned DB lock? Is there an easy way to visualize the status of your study?

Event Type: Webinar

September 24, 2017 - 1:00am (EDT) to September 27, 2017 - 1:00am (EDT)

SCDM 2017

Our eHealth Solutions team hopes to see you at SCDM in Orlando! We invite you to join Bioclinica eHealth Solutions Director, Data Strategy and Solutions Karen McPoyle for her Session 1 discussion on Sept. 25th from 10:45 am to 12:15, Answering the Age Old Question, "Are We There Yet?"

Event Type: Conference

September 26, 2017 - 11:00am (EDT)

During this webinar, clinical financial experts from Bioclinica will present case studies of how trial sponsors and CROs are:

  • Automating the clinical payments process to improve accuracy and operational efficiency, while gaining greater control over cash management
  • Making accurate and timely financial decisions and projections based on relevant financial and operational data, including payment trends and accurate reforecasting based on trial actuals
  • Quickly and accurately calculating accruals to track current liabilities for payments
  • Providing increased transparency and advanced visibility to the payment process and forecasts for all stakeholders, streamlining reporting and Sunshine Act compliance
  • Increasing site satisfaction and becoming high-performing sites' "partner of choice" by replacing error-prone, manual methods with fast and accurate data-driven processes
Event Type: Webinar

September 27, 2017 - 11:00am (EDT)

This presentation will include a detailed discussion of a number of workflow paradigms for the implementation of the Lugano 2014 assessment in oncology clinical trials. This discussion will also include the use of PET/CT quantitative measurements and the five point scale along with the validation of these approaches to further objectify reader interpretation. The components highlighted in the proposed workflow and discussion points in this webinar are intended to help achieve more uniform and consistent multi-time point imaging assessments in lymphoma clinical trials.

Event Type: Webinar

October 5, 2017 - 1:00am (EDT) to October 8, 2017 - 1:00am (EDT)

Global Site Solutions Summit
Join Bioclinica in Boca Raton, Florida for the Global Site Solutions Summit on October 5-8 where we are delighted to be a premier sponsor and exhibitor. Our Research Network and Financial Lifecycle Solutions will be sharing its extensive experience in a presentation geared toward the site perspective.
Event Type: Conference

October 10, 2017 - 1:00am (EDT) to October 11, 2017 - 1:00am (EDT)

Copenhagen, Denmark

Bioclinica is proud to sponsor OCT Nordics, an event dedicated to enabling local knowledge-sharing, benchmarking and network-building between Nordic biopharma and device industry peers. To discuss outsourcing opportunities with Bioclinica, reach out now to schedule a one-on-one meeting with a member of our team onsite during the two-day event.

Event Type: Conference

October 18, 2017 - 1:00am (EDT) to October 19, 2017 - 1:00am (EDT)

Princeton, New Jersey, USA

Come join Bioclinica experts and build your knowledge of clinical supply essentials, from randomization and trial supply management best practices, to maximizing forecasting technology in global clinical trials. 
Meet with our experts one-on-one in the Bioclinica exhibit to get answers to your most pressing questions. More here on our must-see presentation.

Event Type: Presenting

October 26, 2017 - 1:00am (EDT) to October 27, 2017 - 1:00am (EDT)

Philadelphia, PA

Please visit our RTSM experts in the Bioclinica exhibit and catch the presentation with Amanda Nite and Herag Frankian.

Event Type: Presenting

November 1, 2017 - 1:00am (EDT) to November 4, 2017 - 1:00am (EDT)

10th Clinical Trials on Alzheimer's Disease (CTAD)

Join Bioclinica at CTAD 2017 in Boston, MA, where today's worldwide leaders in the treatment of Alzheimer's disease will meet to discuss new results, candidate therapeutics, and methodological issues important to the development of the next generation of Alzheimer's disease treatments.

Attend poster sessions by Bioclinica's neuroscience team and meet Bioclinica representatives from our Medical Imaging and Biomarkers and Global Clinical Research business segments.

Event Type: Conference

November 2, 2017 - 1:00am (EDT) to November 3, 2017 - 1:00am (EDT)

14th Annual Patient Summit USA 2017

If you believe that the pharma industry's focus should be all about the patient, make sure you are one of 300+ senior pharma executives, regulatory authorities, providers, payers, advocates and patients who will come together to drive change at the Patient Summit USA – where Bioclinica is a Sponsor and a Speaker.

Event Type: Conference

Philadelphia, Pennsylvania, USA

Bioclinica is proud to sponsor CBI’s Risk-Based Trial Management and Monitoring conference, dedicated to reducing the complexity of implementing an efficient RBM methodology and providing real-world strategies to system adoption and process integration. Come visit us in the Bioclinica exhibit and be sure to catch the Bioclinica presentation. For complete session details, please check this webpage for updates.

Event Type: Exhibit

November 12, 2017 - 1:00am (EST) to November 14, 2017 - 1:00am (EST)

DIA Japan 2017

Bioclinica is excited to exhibit at the forthcoming DIA Japan Annual Meeting. Join us on exhibit #39 to learn more about our comprehensive medical imaging, cardiac safety and molecular marker laboratory services. Additional on stand discussions will highlight our leading RTSM and other eHealth solutions. With 30 years of experience, and local offices in China and Japan, Bioclinica leads the industry in providing clarity into the global clinical trials process – so you can make better decisions. Pre-arrange a one-on one meeting here.

Event Type: Conference

November 28, 2017 - 1:00am (EST) to November 29, 2017 - 1:00am (EST)

Partnerships in Clinical Trials, Europe

Bioclinica and our team of experts across all three business segments look forward to PCT Europe in Amsterdam. This is an exceptional opportunity to have a one-on-one with a senior member of Bioclinica, see demonstrations of our industry-leading technologies in our exhibit, and learn about all of the exciting technology innovations and extensive resources that are available to support both sponsors and CROs in the conduct of successful clinical trials. Come visit us at booth #58.  See you in Amsterdam!

Event Type: Conference

On Demand Webinars by Category


Electronic Data Capture (EDC) and Data Management

CDISC Standards Briefing – Get Ready for FDA Submissions
Join Jennifer in this webinar for a detailed briefing on where we stand with CDISC implementation and what's next. Learn about recent activities surrounding CDISC standards, which support the acquisition, exchange, submission and archive of clinical research data and metadata and are accessed in 90 countries.


Clinical Trial Management Systems (CTMS)

Outsourcing to CROs? The Top 5 Reasons to Consider Bringing CTMS and Quality Management/RBM Systems in House
This webinar will focus on the changing landscape around outsourcing and key reasons why sponsors may wish to take a fresh look at relying solely on the CTMS and RBM systems of their CROs, especially in terms of efficiency. Come join our speakers as they explore the topic through case studies and look at ROI considerations associated with different outsourcing options, helping you decide an approach right for you.


Bridging the Gap: Managing and Maintaining CTMS and eTMF Data
In this webinar, clinical trial experts Dirk Beth of arivis, a Bioclinica App xChange Partner, and Bioclinica's Jeremiah Rehm will explore the possibilities of single source data across CTMS/eTMF systems. This approach can bring increased efficiencies in a number of important areas, such as elimination of redundant work processes and reconciliation of CTMS/eTMF data.

Back to Top


Randomization and Trial Supply Management (RTSM)

Agile IRT is here! How can you benefit?
Bioclinica experts will show how evolved software development is being applied to IRT study builds to bring about better timelines, visibility and – most importantly – quality. Participants will find out how leading pharma organizations are already employing live study demos and feedback loops, and as a result, experiencing significant advantages of Agile IRT over conventional IRT build – in many important and unexpected ways.


What Value Does Forecasting and Demand Planning Technology Bring to the Management of the End-to-end Clinical Supply Chain?
Forecasting and demand planning tools provide insight to what is truly happening in a clinical trial. They give the transparency required to make timely and educated decisions with regards to clinical trial supply plans and connect people and processes to streamline the forecasting, planning and optimization of the supply chain.


Risk-Based Monitoring

Outsourcing to CROs? The Top 5 Reasons to Consider Bringing CTMS and Quality Management/RBM Systems in House
This webinar will focus on the changing landscape around outsourcing and key reasons why sponsors may wish to take a fresh look at relying solely on the CTMS and RBM systems of their CROs, especially in terms of efficiency. Come join our speakers as they explore the topic through case studies and look at ROI considerations associated with different outsourcing options, helping you decide an approach right for you.


ICH E6 R2 - Guidance and Road Map of Tools for Navigating the Regulatory Landscape
ICH E6 R2 may be relatively new, but the team at The Avoca Quality Consortium (AQC) has been working on many of the components of this set of regulatory changes for over five years.


What Effect Does ICH E6 R2 Have on Risk-Based Monitoring and Overall Quality Risk Management?
With the aim of improving efficiencies in trial conduct while ensuring participant safety, regulatory guidelines have recently undergone revision. The revision to the ICH Guideline for Good Clinical Practice (E6 R2) primarily addresses quality management with a focus on risk identification, evaluation, control, review and reporting. With the pending adoption of these revised guidelines, it's time to evaluate how your organizational structure and processes will be affected.

Back to Top


Post-Approval Research

Patient Centric Post-Approval Research: It's Time to Rethink How Post-Approval Studies Are Done
With an evolving role and complexities of post-approval studies – and a shift toward patient centric outcomes – it is imperative that we revisit the way post-approval research is conducted.


Conducting Post-Approval Research Requires a Unique Mindset and Specialized Infrastructure. Do You Have What it Takes?
There are fundamental differences in conducting research in pre-market randomized controlled trials (RCT) versus post-approval. These differences are not only in the study intent and objectives but the operations and conduct.


Safety and Relgulatory Solutions

Outsourcing Pharmacovigilance: Pros and Cons and Lessons Learned
As the demand for new therapies increases, so does the need to comply with regulatory requirements across the pharmaceutical industry, which is on the constant lookout for newer, more efficient ways to tackle the ever increasing load of adverse event data. Sometimes the need is driven by a lack of availability of the necessary parts of the system to implement pharmacovigilance on time by first-time marketing authorization holders. Other times, it may be the need to streamline processes and reduce wastage by larger companies, in order to have a more robust and compliant reporting system. More and more companies are looking at outsourcing as a possible solution to their short or long term needs.


Cloud-Based Tool Aims to Improve Global Drug Safety & Regulatory Efficiencies While Remaining Compliant
Keeping up with the increasing and evolving safety and pharmacovigilance obligations around the globe can be a major challenge.

In this webinar, she will discuss upcoming changes in global drug safety regulatory requirements and will demonstrate how Bioclinica's drug safety regulatory intelligence tool, RITrace, can improve efficiencies and help you remain compliant.


Marketing Medicines in the EU - Pharmacovigilance Requirements
In this complimentary webinar the Chief Safety Advisor for Synowledge (a Bioclinica company) provides expert insight into good pharmacovigilance practices (GVP) modules within EU legislation. Any pharmaceutical company wishing to market products within the EU must be aware of their legal requirements under the legislation. This webinar is suitable for all staff working in the safety and regulatory area. It is an opportunity to gain an understanding of the legislation at a high level and ask specific questions relating to your business.


Finding the Right End-to-End Safety Solution for Your Needs
With upcoming changes, including the implementation of E2B(R3) and IDMP standards, the current state of safety reporting in clinical trials can be confusing. Your existing safety system may not be flexible enough to accommodate these changing regulations, which are still moving targets in the details needed for a comprehensive solution with the right level of processes, company-to-company integrations and finalized regional rules.


Financial Lifecycle Solutions

How Improving Site Payments Can Make You the Sponsor/CRO of Choice
In a 2016 CenterWatch survey of 252 global investigative sites, the organization found that "e-clinical technologies are increasing investigative site work burden and performance inefficiencies." With investigative sites under increasing resource constraints, they are becoming far more selective in the companies they choose to do business with.

One of the top selection criteria that clinical sites use to make this determination is whether the sponsor or CRO delivers timely and accurate payments for contracted activities.


Clinical Trial Forecasting: Managing the Challenges and Avoiding the Fines
With globalization, large numbers of sites, recent regulatory requirements and an increasing number of CROs and vendors, clinical trials are constantly becoming more complex. Given that clinical trial costs are one of the biggest expense categories for biopharmaceutical companies—the average cost of bringing a drug to market in the US is estimated to be $1.3-1.7 billion—it's critical that CROs and Sponsors forecast accurately.

However, manual processes have made forecasting of clinical trials challenging, leading to difficulties in reforecasting and cash management (and as a result, difficulties in maintaining site satisfaction) as well as hefty fines.


Medical Imaging

Critical Regulatory Considerations for Imaging Trials: What You Need to Know
Medical Imaging plays a significant role in the conduct of clinical trials and bringing new therapies to market. However, as application of medical imaging in clinical studies grow, so does the complexity of regulations on a trial's conduct. The more sites, patients and modalities in a trial, the more complex the regulatory and workflow compliance.

Back to Top


Cardiac Safety

Recent Advances and Critical Review of The Intensive QT Study As a Replacement to The TQT Study: Are We There Yet?
In July 2013 the US FDA presented an initiative to replace the ICH-E14 mandated Thorough QT (TQT) study with a set of non-clinical assays, collectively termed 'Comprehensive In Vitro Pro-arrhythmia Assay' (CiPA). The non-clinical CiPA paradigm is complemented by an Early Phase cardiac safety assessment, involving routine Phase 1 single and multiple ascending dose (SAD/MAD) studies with intensive ECG (QT) and PK sampling, designated the Intensive QT (IQT) study.

Back to Top


Leader in Clinical Trial
Management Solutions

Bioclinica is organized into three business segments so that we can provide expert service and multifaceted technologies. Our Medical Imaging & Biomarkers segment includes an Imaging Core Lab, a Cardiovascular Safety division, and a Molecular Marker Laboratory. Our eHealth segment comprises eClinical Solutions, Randomization & Trial Supply Management, Safety & Regulatory Solutions, and Financial Lifecycle Solutions. Under the Global Clinical Research segment, we offer a network of research sites, patient recruitment, and a Post-Approval Research division.

RT @scrtrials: Sam Shepard's passing is a reminder of the fight against ALS. 2016 was an important year for discovery.…
bioclinica (4 days ago)
RT @eClinical_Jen: SCDM White Papers on Mobile Health and eSource by the Leading Data Managment Organization #eheal…
bioclinica (5 days ago)
RT @eClinical_Jen: Data Managers - There is a FREE guideline for Good Clinical Data Management Practices here: #ehe…
bioclinica (5 days ago)
RT @Xtalks: IRT Best Practices: How Companies are Accelerating Timelines While Improving Quality Live webinar with @bioclinica…
bioclinica (5 days ago)
Cardiovascular imaging use is growing in non-cardiovascular areas #ClinicalTrials. See where in Tim Crowe's blog…
bioclinica (5 days ago)
A quick primer on analyzing risk in business processes by our Director of RTSM Delivery Nick Hargaden
bioclinica (5 days ago)

Latest Blogs: